No definition available.
Benign neoplasm: salivary glands, exclude unknown (D119)
CD2_BENIGN_SALIVARY_KNOWN
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
473681 |
1. Apply sex-specific ruleNone |
473681 |
2. Check conditionsNone |
473681 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
3024 |
4. Check minimum number of eventsNone |
3024 |
5. Include endpointsNone |
3024 |
6. Filter based on genotype QC (FinnGen only) |
2921 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
Similar endpoints
↥List of similar endpoints to Benign neoplasm: salivary glands, exclude unknown (D119) based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of major salivary glands
- Benign neoplasm of major salivary glands
- Benign neoplasms
- Benign neoplasms
- Neoplasms
Similar with less cases:
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | |||
Whole population | 19916 | 10324 | 9492 |
Only index persons | 18679 | 9842 | 8837 |
Unadjusted period prevalence (%) | |||
Whole population | 0.28 | 0.30 | 0.27 |
Only index persons | 0.35 | 0.36 | 0.34 |
Median age at first event (years) | |||
Whole population | 60.67 | 60.79 | 60.55 |
Only index persons | 59.98 | 60.13 | 59.82 |
-FinnGen-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 2921 | 1499 | 1422 |
Unadjusted period prevalence (%) | 0.65 | 0.59 | 0.71 |
Median age at first event (years) | 60.04 | 57.27 | 62.95 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_SALIVARY_KNOWN and mortality.
Females
Parameter | HR [95% CI] | p-value |
---|---|---|
CD2_BENIGN_SALIVARY_KNOWN | 1.245 [1.13, 1.37] | < 0.001 |
Birth year | 0.995 [0.99, 1.0] | 0.204 |
During the follow-up period (1.1.1998 — 31.12.2019), 1747 out of 9004 females with CD2_BENIGN_SALIVARY_KNOWN died.
Males
Parameter | HR [95% CI] | p-value |
---|---|---|
CD2_BENIGN_SALIVARY_KNOWN | 1.447 [1.31, 1.6] | < 0.001 |
Birth year | 0.988 [0.98, 1.0] | 0.008 |
During the follow-up period (1.1.1998 — 31.12.2019), 2033 out of 8254 males with CD2_BENIGN_SALIVARY_KNOWN died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_SALIVARY_KNOWN.N-year risk | Females | Males |
---|---|---|
1 | 0.106% | 0.249% |
5 | 0.728% | 1.388% |
10 | 1.937% | 4.022% |
15 | 3.849% | 7.767% |
20 | 6.407% | 12.739% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_SALIVARY_KNOWN – Benign neoplasm: salivary glands, exclude unknown (D119)
GWS hits: 1